Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV000788591 | SCV000927752 | uncertain significance | not provided | 2018-06-15 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002501030 | SCV002783607 | uncertain significance | Polycystic kidney disease, adult type | 2024-03-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004027371 | SCV005005225 | uncertain significance | Inborn genetic diseases | 2023-11-29 | criteria provided, single submitter | clinical testing | The c.3655A>G (p.M1219V) alteration is located in exon 15 (coding exon 15) of the PKD1 gene. This alteration results from a A to G substitution at nucleotide position 3655, causing the methionine (M) at amino acid position 1219 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |